ASPIRE PHARMACEUTICALS PRIVATE LIMITED

In their own words

ASPIRE PHARMACEUTICALS PRIVATE LIMITED have nurtured this evolving business through increased focus and investments. The key segments we are targeting are dermatology, ophthalmology and oncology. Our focus is on improving patient outcomes either by addressing unmet medical needs or by enhancing patient convenience through differentiated dosage forms. Our initiatives in this segment cover the entire value chain, from in-licensing early-to-late stage clinical candidates, as well as getting access to on-market patented products. .We provide high quality generic and branded medicines at affordable costs to patients and doctors in more than 100 countries worldwide. Our products have the hallmark of technology-based differentiation and cover the full range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams and liquids. The therapeutic segments covered by our portfolio of over 2000 molecules include psychiatry, anti-infectives, neurology, cardiology, orthopaedic, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. We provide a range of over-the-counter (OTC) / consumer healthcare products. Faringosept (sore throat), Revital (vitamins) and Volini (topical analgesics) are a few of our flagship OTC brands that are marketed in several countries globally. There are other category defining brands such as Coldact & Flustat (cold & flu), Brustan, Painamol & Paduden (analgesics), Aspenter, Aspacardin, Nudrate & Fortifikat (lifestyle OTCs), Gestid (digestives) and Chericof (cough).

Written by the company on its public Startup India profile. Not verified by us.